AP
UTHR icon

Atwood & Palmer’s United Therapeutics UTHR Stock Holding History

Atwood & Palmer’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.3M Sell
61,479
-957
-2% -$539K 1.78% 23
2026
Q1 		$37M Sell
62,436
-1,096
-2% -$546K 2.09% 18
2025
Q4 		$31M Sell
63,532
-348
-0.5% -$162K 1.76% 26
2025
Q3 		$26.8M Sell
63,880
-44
-0.1% -$14.8K 1.57% 26
2025
Q2 		$18.4M Buy
63,924
+228
+0.4% +$68.1K 1.15% 40
2025
Q1 		$19.6M Sell
63,696
-879
-1% -$301K 1.36% 34
2024
Q4 		$22.8M Buy
64,575
+519
+0.8% +$191K 1.56% 29
2024
Q3 		$23M Buy
64,056
+294
+0.5% +$99.3K 1.56% 28
2024
Q2 		$20.3M Buy
63,762
+165
+0.3% +$43.7K 1.54% 28
2024
Q1 		$14.6M Buy
63,597
+3,725
+6% +$841K 1.11% 41
2023
Q4 		$13.2M Buy
59,872
+303
+0.5% +$69.8K 1.06% 42
2023
Q3 		$13.5M Buy
59,569
+580
+1% +$134K 1.18% 42
2023
Q2 		$13M Buy
58,989
+430
+0.7% +$95.2K 1.16% 37
2023
Q1 		$13.1M Buy
58,559
+2,372
+4% +$585K 1.23% 34
2022
Q4 		$15.6M Buy
56,187
+720
+1% +$182K 1.41% 27
2022
Q3 		$11.6M Buy
55,467
+679
+1% +$152K 1.15% 35
2022
Q2 		$12.9M Buy
+54,788
New +$11.1M 1.26% 35

Other funds holding UTHR

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM

Atwood & Palmer's UTHR Position: Q2 2026 in Review

Atwood & Palmer reduced its United Therapeutics (UTHR) stake by 1.5% in Q2 2026, selling an estimated $539K and leaving 61,479 shares worth $33.3M. The position accounts for 1.78% of the portfolio, ranked #23.

Atwood & Palmer first reported a position in UTHR in Q2 2022 and has held it in 17 quarters since. The position peaked at $37M in Q1 2026. 83 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Atwood & Palmer held 61,479 shares of United Therapeutics worth $33.3M as of Q2 2026.
  • Atwood & Palmer sold 957 United Therapeutics shares in Q2 2026, an estimated $539K.
  • United Therapeutics made up 1.78% of Atwood & Palmer's portfolio in Q2 2026, its #23 holding.
  • Atwood & Palmer first reported a position in United Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • Atwood & Palmer's United Therapeutics position peaked at $37M in Q1 2026.
  • 83 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.